Strides Pharma Science Ltd. benchmarking: Perfomance to industry peers

Financial

	Strides Pharma Scien	Marksans Pharma	Procter&Gamble Healt
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	230.0 .	25.0 .	n/a
Number of ANDA's Approved By USFDA	215.0 .	13.0 .	n/a
R&D as a % of Total Sales	1.84 %	2.0 %	n/a
Financials
5 yr Average ROE	23.7 %	17.57 %	36.03 %
5yr average Equity Multiplier	2.62	1.33	1.79
5yr Average Asset Turnover Ratio	0.6	0.9	0.77
5yr Avg Net Profit Margin	12.9 %	14.56 %	19.19 %
Price to Book	3.09	3.25	15.79
P/E	21.43	24.86	31.9
5yr Avg Cash Conversion Cycle	-51.45 Days	71.65 Days	-155.74 Days
Inventory Days	69.05 Days	89.77 Days	36.01 Days
Days Receivable	60.35 Days	65.99 Days	40.92 Days
Days Payable	225.58 Days	88.81 Days	215.28 Days
5yr Average Interest Coverage Ratio	0.72	38.03	500.05
5yr Avg ROCE	10.5 %	21.95 %	30.21 %
5yr Avg Operating Profit Margin	12.17 %	20.32 %	27.53 %
5 yr average Debt to Equity	1.01	0.02	0.0
5yr CAGR Net Profit	68.01 %	10.03 %	4.02 %
5yr Average Return on Assets	10.97 %	13.19 %	15.5 %
Shareholdings
Promoter Holding	27.86 %	43.87 %	51.82 %
Share Pledged by Promoters	44.13 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.21 %	-4.73 %	-0.03 %
Change in Mutual Fund Holding (3 Yrs)	0.16 %	2.97 %	3.66 %

Business

	Strides Pharma Scien	Marksans Pharma	Procter&Gamble Healt
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Vitamins & Suppliments 0 Anti-Cancer 0 Anti-Hair Fall 0 Central Nervous System 0 Antibiotics 0 Anti-allergic 0 Miscellaneous 0 Gastro-intestinal 0 Anti-diabetic 0 Cough and colds 0 Cardiovascular system (CVS) 0 Pain management 0	Product Wise Break-Up Anti-Cancer 0 Antibiotics 0 Vitamins & Suppliments 0 Miscellaneous 0 Gastro Intestinal 8.5 Central Nervous System (CNS) 8.1 Pain Management 44.0 Pharmaceutical 0 Anti-Hair Fall 0 Cough and colds 14.0 Cardiac Science 9.2 Anti-allergic 0 Anti - Diabetes 1.6 Others 14.6	-
Location Wise Break-Up	Location Wise Break-Up North America 53.68 Europe 21.77 Africa 10.11 Australia 9.63 Asia Pacific 0.49 India 0.35 International 0 Domestic 0 Others 3.97	Location Wise Break-Up India 0 North America 52.8 Europe 32.9 Domestic 0 Australia 9.2 Africa 0 Asia Pacific 0 International 0 Others 5.1	Location Wise Break-Up India 0 North America 0 Europe 0 Domestic 93.19 Australia 0 Africa 0 Asia Pacific 0 International 6.81
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical 100.0	-	-
Customer Segment	Customer Segment Regulated market 83.0 Emerging Market 11.0 Institutional Business 0 OTC 0 Rx 0 Others 6.0	Customer Segment Regulated market 0 OTC 78.8 Emerging Market 0 Rx 21.2 Institutional Business 0	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 43.68 Asia ex India 22.48 North America 18.17 Europe 10.2 Africa 5.48 Australia 0	-	-
Asset Break-Up	Asset Break-Up Pharmaceutical 97.35 Bio-Pharmaceutical 2.65 India 0	-	Asset Break-Up India 100.0 Pharmaceutical 0 Bio-Pharmaceutical 0

Strides Pharma Science Ltd.

Strides Pharma Science Ltd.

Financial

Business

SIGN UP FOR FREE